SCHEMBL24956357

SCHEMBL24956357

CO[C@H](C)CNc1cc(C(=O)OC(C)(C)C)ccc1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 1/20 0.43
▸ LNPEP Q9UIQ6 6/20 0.41
▸ ERAP2 Q6P179 2/20 0.41
▸ HDAC1 Q13547 1/20 0.39
▸ SLC7A5 Q01650 1/20 0.39
▸ CA12 O43570 1/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ CA14 Q9ULX7 1/20 0.39
▸ AAK1 Q2M2I8 2/20 0.38
▸ MAPT P10636 3/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ GAA P10253 2/20 0.37
▸ HSD17B10 Q99714 2/20 0.37
▸ GLA P06280 1/20 0.37
▸ HPGD P15428 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29160321 1.00 ALOX15 (0.43) ALOX15LNPEPERAP2HDAC1SLC7A5
SCHEMBL26237173 0.89 LNPEP (0.51) LNPEPERAP2HDAC1MAPTNPC1
SCHEMBL23273557 0.86 ALOX15 (0.42) ALOX15LNPEPERAP2HDAC1SLC7A5
SCHEMBL26541098 0.83 PRKCI (0.44) LNPEPERAP2HDAC1MAPTNPC1
SCHEMBL25372434 0.83 PTGER4 (0.49) LNPEPERAP2MAPTNPC1RAB9A
SCHEMBL25372438 0.83 PTGER4 (0.49) LNPEPERAP2MAPTNPC1RAB9A
SCHEMBL23273555 0.80 PTGER4 (0.57) ALOX15LNPEPERAP2HDAC1SLC7A5
SCHEMBL3720352 0.80 ALOX15 (0.46) ALOX15LNPEPERAP2HDAC1SLC7A5
SCHEMBL23286842 0.78 LNPEP (0.43) LNPEPERAP2HDAC1AAK1MAPT
SCHEMBL28353995 0.78 LNPEP (0.53) ALOX15LNPEPERAP2HDAC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4271674-B9 CARBOXY-BENZIMIDAZOLE GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES INC (US) 2026-03-11 — — EP disclosed
US-12570642-B2 GLP-IR modulating compounds GILEAD SCIENCES, INC. (US) 2026-03-10 — — US disclosed
EP-4691554-A2 GLP-1R MODULATING COMPOUNDS Gilead Sciences, Inc. (US) 2026-02-11 — — EP disclosed
EP-4271672-B1 CARBOXY-BENZIMIDAZOLE GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES INC (US) 2025-12-03 — — EP disclosed
EP-4271674-B3 CARBOXY-BENZIMIDAZOLE GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES INC (US) 2025-12-03 — — EP disclosed
US-20250312352-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2025-10-09 — — US disclosed
EP-4520393-A2 CARBOXY-BENZIMIDAZOLE GLP-1R MODULATING COMPOUNDS Gilead Sciences, Inc. (US) 2025-03-12 — — EP disclosed
EP-4271674-B1 CARBOXY-BENZIMIDAZOLE GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES INC (US) 2025-02-12 — — EP disclosed
US-20240199589-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2024-06-20 — — US disclosed
US-11858918-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2024-01-02 — — US disclosed
US-11858918-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2024-01-02 — — US disclosed
US-11858918-B2 GLP-1R modulating compounds GILEAD SCIENCES, INC. (US) 2024-01-02 — — US disclosed
EP-4271674-A1 CARBOXY-BENZIMIDAZOLE GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2023-11-08 — — EP disclosed
EP-4271672-A1 CARBOXY-BENZIMIDAZOLE GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2023-11-08 — — EP disclosed
US-20230102927-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2023-03-30 — — US disclosed
US-20230021705-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2023-01-26 — — US disclosed
US-20230021705-A1 GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2023-01-26 — — US disclosed
WO-2022225941-A1 CARBOXY-BENZIMIDAZOLE GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2022-10-27 — — WO disclosed
WO-2022225914-A1 CARBOXY-BENZIMIDAZOLE GLP-1R MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2022-10-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250312352-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 ALOX15 3030/4885LNPEP 1751/4885ERAP2 1694/4885
US-20230021705-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 ALOX15 3030/4885LNPEP 1751/4885ERAP2 1694/4885
US-11858918-B2 GLP-1R modulating compounds GLP1R, GIPR, GPR119 ALOX15 3030/4885LNPEP 1751/4885ERAP2 1694/4885
US-20240199589-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 ALOX15 3030/4885LNPEP 1751/4885ERAP2 1694/4885
US-20230102927-A1 GLP-1R MODULATING COMPOUNDS GLP1R, GIPR, GPR119 ALOX15 3030/4885LNPEP 1751/4885ERAP2 1694/4885
US-12570642-B2 GLP-IR modulating compounds GLP1R, GIPR, GPR119 ALOX15 4535/4885LNPEP 1525/4885ERAP2 2436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback